Mouse Model News and Research

RSS

Research suggests new strategies for developing psoriasis therapies

Psoriasis is a skin disorder that affects at least 100 million individuals worldwide. Its economic impact is more than $10 billion annually in the U.S. alone.

11 Dec 2019

Bruker launches Luxendo TruLive3D Imager light-sheet imaging system

At the 2019 joint meeting of the American Society for Cell Biology and European Molecular Biology Organization, Bruker today announced the launch of the Luxendo TruLive3D Imager light-sheet imaging system.

From Bruker Nano Surfaces and Metrology 11 Dec 2019

Mitochondrial dysfunction may underlie prolonged muscle weakness after sepsis

Damage to energy-producing mitochondria may underlie prolonged muscle weakness following a sepsis-like condition in mice, according to a new study published today in eLife.

10 Dec 2019

New nanoparticle innovation detects vascular calcification in atherosclerosis

Heart disease and stroke are the world's two most deadly diseases, causing over 15 million deaths in 2016 according to the World Health Organization.

9 Dec 2019

Important biomarker may help in determining prognosis of brain cancer patients

A common virus that is harmless to most individuals may produce an important biomarker in determining the prognosis of brain cancer patients, according to a recent study published by a student researcher at the University of Cincinnati.

9 Dec 2019

New approach to broadly acting, highly effective HIV vaccine

Researchers have reported a major advance in the creation of a successful HIV vaccine that is not produced by the host animal.

9 Dec 2019

Researchers successfully develop imaging technology of conjunctival goblet cells

Goblet cells are epithelial cells that produce mucins and disperse tears which help the surface of eyes maintain the wet environment. Goblet cells are closely related to autoimmune disease including dry eyes and chemical burns. Therefore, it is very important to examine the status of goblet cells to better understand and diagnose ocular disease.

5 Dec 2019

New discovery on chromosomal function may shed light on human health and disease

Researchers have discovered key mechanisms and structural details of a fundamental biological process - how a cell nucleus and its chromosomal material reorganizes itself after cell division

5 Dec 2019

Study finds it may be possible to treat endometriosis using an investigational cancer drug

Researchers have shown that painful endometriosis symptoms could be alleviated using an investigational cancer drug.

3 Dec 2019

Inhibition of a protease could improve the treatment of IBD, study shows

Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Centro de Investigaciones Biológicas of the Consejo Superior de Investigaciones Científicas have identified the protease MT1-MMP as a possible future target for drugs to treat inflammatory bowel disease.

3 Dec 2019

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can fuel cancer development and suppress immune response to the disease.

3 Dec 2019

Painful endometriosis symptoms could be reduced with a cancer drug

The painful symptoms of endometriosis - a chronic condition which affects millions of women - could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

2 Dec 2019

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

Scientists have identified a protein in fruit flies that can be targeted to reverse the effects of disease-causing mutations in mitochondrial genes. The discovery could provide clues about how to counteract human mitochondrial diseases, for which there is currently no cure.

28 Nov 2019

Researchers reveal ineffectiveness of some treatments in tackling early-stage lung cancer

Researchers from Tohoku University and Tohoku University Hospital have revealed why some existing cancer treatments are ineffective in tackling the early-stages of lung cancer. A team led by Professor Tetsuya Kodama investigated the ability of anti-cancer agents to affect early-stage lung metastatic tumors.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.

26 Nov 2019

New way to thwart HIV infection at early stages

1.7 million. That's how many people are infected with the human immunodeficiency virus (HIV) each year worldwide. 1.7 million people who are condemned to lifelong antiretroviral therapy (ART) or risk developing fatal AIDS . Out of the 37.9 million people living with HIV (PLWH), 22.3 million have access to ART, allowing them to have an almost normal lifespan.

26 Nov 2019

Researchers find new way to protect against disease in MS model

Researchers have found a new and unexpected way of preventing disease in a preclinical model of multiple sclerosis (MS).

26 Nov 2019

Hops compounds may combat metabolic syndrome by changing the gut microbiome

Compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver, new research at Oregon State University suggests.

26 Nov 2019

Mouse Model News and Research

Research suggests new strategies for developing psoriasis therapies

Bruker launches Luxendo TruLive3D Imager light-sheet imaging system

Mitochondrial dysfunction may underlie prolonged muscle weakness after sepsis

New nanoparticle innovation detects vascular calcification in atherosclerosis

Important biomarker may help in determining prognosis of brain cancer patients

New approach to broadly acting, highly effective HIV vaccine

Researchers successfully develop imaging technology of conjunctival goblet cells

New discovery on chromosomal function may shed light on human health and disease

Study finds it may be possible to treat endometriosis using an investigational cancer drug

Inhibition of a protease could improve the treatment of IBD, study shows

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Painful endometriosis symptoms could be reduced with a cancer drug

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

Researchers reveal ineffectiveness of some treatments in tackling early-stage lung cancer

FDA-approved anti-inflammatory drug delays onset of ALS in mice

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

New way to thwart HIV infection at early stages

Researchers find new way to protect against disease in MS model

Hops compounds may combat metabolic syndrome by changing the gut microbiome

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News